Showing 1801-1810 of 8179 results for "".
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
https://practicaldermatology.com/series/dermwire-tv/study-examines-association-between-childhood-bmi-and-risk-of-developing-imsds/27004/In this week's DermwireTV, a new study examines the relationship between childhood BMI and skin diseases; phase 3 data sheds new light on dupilumab’s effect on inflammatory biomarkers in pediatric AD patients; and the president and CEO of Evolus discusses trends in the injectables market.FDA Approval for Delgocitinib
https://practicaldermatology.com/series/c-suite-chats/fda-approval-for-delgocitinib/36650/Robert Spurr, EVP, North America for LEO Pharma, discusses the importance of an FDA-approved option for treating moderate-to-severe chronic hand eczema in adults.Calling Out Hesitation on Systemics
https://practicaldermatology.com/programs/practical-dermatology/calling-out-hesitation-on-systemics/35703/The latest news and updates, plus Jason E. Hawkes, MD, MS, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss why dermatologists should not be reluctant to prescribe systemic therapies, and Linda F. Stein Gold, MD, discusses the importance of an ever-expanding aVtama Approved for AD in Adults and Children
https://practicaldermatology.com/series/dermwire-tv/vtama-approved-ad-adults-and-children/30079/In this week's DermwireTV, the FDA approves Vtama (tapinarof cream 0.1%) for atopic dermatitis in adults and children; the FDA approves Nemluvio (nemolizumab) for moderate-to-severe AD; and the president of Nuance Medical discusses the acquisition of scar treatment brand, Biocorneum.Science of Skincare Summit 2024: On the FDA Approval of Emrosi for Rosacea
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-on-the-fda-approval-of-emrosi-for-rosacea/29276/At the Science of Skincare Summit in Austin, Practical Dermatology caught up with Chief Medical Editor Neal Bhatia, MD, and James Del Rosso, DO, a dermatologist and Editor in Chief of Clinical Dermatology at the Journal of Clinical and Aesthetic Dermatology (JCAD), who shared insights and thoughts oPDT and Skin Cancer
https://practicaldermatology.com/series/pdt-in-practice/pdt-and-skin-cancer/20211/Dr. Joel L. Cohen, a board-certified dermatologist practicing in Denver, talks about how photodynamic therapy (PDT) has expanded treatment options for patients with skin cancers, and shares insights on how it can be integrated with care for patients with pre-cancerous abnormalities to prevent squamoWomen and Acne: Special Considerations
https://practicaldermatology.com/conferences/scale-2023/women-and-acne-special-considerations/20189/Julie C. Harper, MD, discusses the role that oral contraceptives and spironolactone play in treating female acne and reviews some of the potential risks of these therapies.DermWireTV: Olumiant Approved for AA; Radiesse + Launch; Derms as Influencers; VCS
https://practicaldermatology.com/topics/practice-management/dermwiretv-olumiant-approved-for-aa-radiesse-launch-derms-as-influencers-vcs/20107/Olumiant (baricitinib) from Eli Lilly and Company is approved to treat adult patients with severe alopecia areata. Dermatologists rank as top influencers of consumers’ decisions to have cosmetic procedures, according to results of the American Society for Dermatologic Surgery (ASDS) Consumer SurveyAdvocating for Dermatology: The Benefits of Being Involved
https://practicaldermatology.com/topics/practice-management/advocating-for-dermatology-the-benefits-of-being-involved/20087/Neal Bhatia, MD shares his appreciation for being able to have served as the American Academy of Dermatology’s Vice President for the last year. He shares his thoughts on the importance of getting involved and advocating for the specialty.Embracing AI
https://practicaldermatology.com/topics/practice-management/embracing-ai/20080/Artificial intelligence is something dermatologists should be embracing as augmented intelligence. Anthony Rossi, MD says this intelligence will allow us to better diagnose, assess, and treat patients with everything from acne to melanoma.